Involvement Of The Cannabimimetic Compound, N-palmitoyl-ethanolamine, In Inflammatory And Neuropathic Conditions: Review Of The Available Pre-clinical Data, And First Human Studies

Pain (Neuropathies, in general)

Key Findings

These heterogeneous data, together with previous findings reviewed here, substantiate the hypothesis that N-palmitoyl-ethanolamine (PEA) is an endogenous mediator whose levels are increased following neuroinflammatory or neuropathic conditions in both animals and humans, possibly to exert a local anti-inflammatory and analgesic action.

Information and Links


Link: Involvement Of The Cannabimimetic Compound, N-palmitoyl-ethanolamine, In Inflammatory And Neuropathic Conditions: Review Of The Available Pre-clinical Data, And First Human Studies

Year: 2005

DOI: 10.1016/j.neuropharm.2005.01.001


Ratings

(How Ratings Work)

Pain (Neuropathies, in general) — 3


Likely probability of the efficacy of cannabis for treatment of Pain (Neuropathies, in general) according to the results found in this study.

Drugs Used

N-palmitoyl-ethanolamine (PEA)